GLMD
Galmed Pharmaceuticals
$0.53
+$0.01 (+2.73%)Jul 27, 2026
Key metrics
The numbers that frame GLMD today
- Market cap
- $3.48M
- P/E (TTM)
- -0.3
- EV / FCF
- -0.2
- ROIC
- -86%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.41
- 52wk High
- $2.09
Growth
Revenue and earnings trend for GLMD
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about GLMD
Is Galmed Pharmaceuticals a good buy?
No. Galmed Pharmaceuticals has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Galmed Pharmaceuticals is selling at a very high price.
What is the market capitalization of GLMD?
Galmed Pharmaceuticals's market capitalization is $3.48M.
What is the P/E ratio for GLMD stock?
Galmed Pharmaceuticals's current P/E ratio is -0.3.
What is the 52-week high for GLMD stock?
The 52-week high for Galmed Pharmaceuticals is $2.09. The current close of $0.53 is 74.8% below that high.
What is the 52-week low for GLMD stock?
The 52-week low for Galmed Pharmaceuticals is $0.41. The current close of $0.53 is 28.2% above that low.
Does GLMD stock pay dividends?
Galmed Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for GLMD?
Galmed Pharmaceuticals's Debt / Equity ratio is 0.